ArticleCureus2026
Acute Ischemic Stroke as the Initial Manifestation of Antiphospholipid Syndrome After SARS-CoV-2 Infection in a 17-Year-Old Patient.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stroke is an unusual condition in young adults, but when it presents in this population, there are specific causes that differ from those in older adults. When this occurs, it is necessary to make an extensive assessment to establish a final diagnosis. One of these causes, as in the case presented, is antiphospholipid syndrome (APS), which can present as venous or arterial thrombosis. There are conditions that act as triggers for the formation of antiphospholipid antibodies (aPL) and the development of APS. This report illustrates these points by presenting a young patient who developed APS after a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection that acted as a trigger, along with probable genetic susceptibility factors, and was diagnosed in accordance with guidelines 12 weeks after initial presentation. He was successfully treated with rescue mechanical thrombolysis, with favorable outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.